$4.43
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now
Overview
52-week range
$1.30
$8.00
47% of range
Avg surprise (last 2)
-21.1%
Avg reaction (last 2)
-2.0%
50% positive
Latest IV / EM
217%
EM ±33.9% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.11 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.22 | $-0.18 | -22.2% | +62.1% | +1.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.30 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.30 | $-0.25 | -20.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.58 | — | — | — | -5.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.72 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.59 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.72 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.73 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.84 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.87 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-15M | $-19M | — | $-10M | $-10M | $-18M | — | $-23M |
| Net income | $-13M | $-19M | — | $-10M | $-10M | $-18M | — | $-22M |
| EPS (diluted) | $-0.11 | $-0.22 | — | $-0.30 | $-0.30 | $-0.58 | — | $-0.72 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $10M | $3M | $1M | $1M | $1M | $4M | $1M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $219M | $235M | $94M | $15M | $21M | $28M | $46M | $56M |
| Total assets | $219M | $235M | $94M | $15M | $21M | $28M | $46M | $56M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $13M | $17M | $7M | $5M | $5M | $5M | $10M | $8M |
| Total equity | $207M | $219M | $87M | $9M | $16M | $22M | $36M | $48M |